KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Shares Issued (2020 - 2024)

Historic Shares Issued for AbCellera Biologics (ABCL) over the last 4 years, with Q3 2024 value amounting to $227000.0.

  • AbCellera Biologics' Shares Issued fell 1132.81% to $227000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $1.8 million, marking a year-over-year decrease of 3699.38%. This contributed to the annual value of $4.6 million for FY2021, which is 9911.73% down from last year.
  • As of Q3 2024, AbCellera Biologics' Shares Issued stood at $227000.0, which was down 1132.81% from $461000.0 recorded in Q2 2024.
  • Over the past 5 years, AbCellera Biologics' Shares Issued peaked at $521.9 million during Q4 2020, and registered a low of $124000.0 during Q1 2020.
  • In the last 4 years, AbCellera Biologics' Shares Issued had a median value of $475500.0 in 2023 and averaged $37.9 million.
  • Examining YoY changes over the last 5 years, AbCellera Biologics' Shares Issued showed a top increase of 124645.67% in 2021 and a maximum decrease of 9964.86% in 2021.
  • Quarter analysis of 4 years shows AbCellera Biologics' Shares Issued stood at $521.9 million in 2020, then plummeted by 99.65% to $1.8 million in 2021, then tumbled by 86.04% to $256000.0 in 2023, then fell by 11.33% to $227000.0 in 2024.
  • Its last three reported values are $227000.0 in Q3 2024, $461000.0 for Q2 2024, and $892000.0 during Q1 2024.